Skip to main content

Crossject : Fin du programme de conversion des OC émises en 2019

Written by Customer Service on . Posted in Public Companies.

Communiqué de PresseFin du programme de conversion
des OC émises en 2019 Dijon, le 1er juillet  2020CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un portefeuille de médicaments dédiés aux situations d’urgence, annonce la fin du programme de conversion des obligations convertibles (OC) émises en  décembre 2019.Les obligations convertibles émises en décembre 2019 ont été intégralement converties. Ces conversions ont permis à Crossject de renforcer ses fonds propres pour un montant de 5,7 M€ par création de 3 680 612 actions.La conversion de la totalité des OC avant son terme, initialement prévu au 31 décembre 2021, illustre une nouvelle fois la confiance des investisseurs européens qui avaient souscrit à cette émission, et de Gemmes Venture, par ailleurs actionnaire historique de Crossject, dans le potentiel de développement de Crossject. A l’issue de ces conversions, la participation de Gemmes Venture est passée de 27,8% à 29,1%.Prochaine publication : 18 septembre 2020 (après bourse) : Résultats semestriels 2020Contacts :  A propos de CROSSJECT • www.crossject.comCrossject (Code ISIN : FR0011716265 ; Mnémo : ALCJ ; LEI :969500W1VTFNL2D85A65) développe et commercialisera prochainement un portefeuille de médicaments dédiés aux situations d’urgence : épilepsie, overdose, choc allergique, migraine sévère, crise d’asthmes…Grâce à son système breveté d’auto-injection sans aiguille, Crossject ambitionne de devenir le leader mondial des médicaments d’urgence auto-administrés. La société est cotée sur le marché Euronext Growth Paris depuis 2014, et bénéficie de financements par Bpifrance notamment.Pièce jointe2020_07_01_Crossject _fin du programme de conversion des OC émises en 2019_VDEF

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.